Ligand · 382
382 · (R)-2-(2-(1H-1,2,4-triazol-1-yl)benzyl)-N-(2,2-difluoro-2-(piperidin-2-yl)ethyl)oxazolo[4,5-c]pyridin-4-amine
382, (R)-2-(2-(1H-1,2,4-triazol-1-yl)benzyl)-N-(2,2-difluoro-2-(piperidin-2-yl)ethyl)oxazolo[4,5-c]pyridin-4-amine (C22 H23 F2 N7 O, 439.5 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site…
- Component
- 382
- Formula
- C22 H23 F2 N7 O
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
382 in 2 structures; the first of them:
- 1ZGI · thrombin in complex with an oxazolopyridine inhibitor 21 · 382 A1001 · binds HIS57, TYR60A, TRP60D, GLU97A, ASN98, LEU99, ILE174, ASP189 and 11 more
- 1ZGI · Thrombin in complex with an oxazolopyridine inhibitor 21 · 382 A1001 · binds HIS57, TYR60A, TRP60D, GLU97A, ASN98, LEU99, ILE174, ASP189 and 11 more
Residues it binds most
GLU 2, CYS 2, GLY 2, SER 2, TRP 2, ALA 2, ASN 2, ASP 2, HIS 2, ILE 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.